Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: percocet / vicodin attending: chief complaint: chest pain/dyspnea on exertion major surgical or invasive procedure: mitral valve repair(28mm annuloplasty band) and three vessel coronary artery bypass grafting utilizing the left internal mammary artery to left anterior descending with saphenous vein grafts to diagonal and obtuse marginal. history of present illness: 66 year old gentleman with known coronary artery disease who has undergone stenting in the past who in novemeber was admitted to a hospital in and treated for heart failure, severe pulmonary hypertension and bilateral pneumonia. a cardiac catheterization was performed which revealed severe left main and two vessel disease. given the severity of his disease, he has been referred for surgical rvascularization. he has felt significantly better with diuresis however continues to have some chest pain and dypnea on exertion. past medical history: -cad s/p ptca and stenting in past (ptca , ptca/stent , cypher stent prox lcx) -dyslipidemia -hypertension -copd -chf (episode ) bnp up to 1369 -recent pneumonia -nephrolithiasis -pulmonary hyertension -barrett's esophagus -s/p cholescystectomy social history: lives with: fiancee. divorced with 4 children. half the year is spent living in and the other half in . occupation: retired tobacco: former 35 pack year. quit . etoh: occassional family history: brother with cabg at age 66 physical exam: pulse: 74 resp: 20 o2 sat: 98% b/p right: 109/61 left: 117/79 height: 5' 10.5" weight: 182lbs general: well-developed, well-nourished male in no acute distress skin: dry intact heent: perrla eomi neck: supple full rom chest: lungs clear bilaterally heart: rrr irregular murmur abdomen: soft non-distended non-tender bowel sounds + extremities: warm , well-perfused edema/varicosities: none neuro: grossly intact pulses: femoral right/left: 2+ dp right/left: 2+ pt /left: 2+ radial right/left: 2+ carotid bruit right/left: none pertinent results: 05:50am blood wbc-6.4 rbc-3.19* hgb-9.7* hct-28.8* mcv-90 mch-30.4 mchc-33.7 rdw-15.2 plt ct-246 12:18pm blood wbc-14.5*# rbc-3.09*# hgb-9.2*# hct-27.2*# mcv-88 mch-29.6 mchc-33.6 rdw-15.4 plt ct-155 12:18pm blood neuts-77.5* lymphs-18.9 monos-2.5 eos-0.7 baso-0.5 05:50am blood plt ct-246 05:50am blood pt-13.6* inr(pt)-1.2* 12:18pm blood pt-16.1* ptt-42.4* inr(pt)-1.4* 05:50am blood glucose-95 urean-24* creat-0.9 na-142 k-4.3 cl-104 hco3-31 angap-11 01:26pm blood urean-11 creat-0.8 cl-120* hco3-22 05:50am blood mg-2.4 03:09am blood calcium-8.5 phos-3.3 mg-2.6 , m 66 radiology report chest (pa & lat) study date of 9:27 am , fa6a 9:27 am chest (pa & lat) clip # reason: evaluate left effusion medical condition: 66 year old man with s/p cabg reason for this examination: evaluate left effusion final report pa and lateral chest on history: status post cabg. evaluate left pleural effusion. impression: pa and lateral chest compared to : small left pleural effusion is stable, and there is no pneumothorax. mild-to-moderate enlargement of the cardiac silhouette is stable but there has been a decrease in vascular plethora consistent with improving cardiac function. dr. approved: 1:36 pm echocardiography report , (complete) done at 9:10:33 am final referring physician information , r. , division of cardiothorac , status: inpatient dob: age (years): 66 m hgt (in): 70 bp (mm hg): 123/67 wgt (lb): 185 hr (bpm): 78 bsa (m2): 2.02 m2 indication: intraoperative tee for cabg and mitral valve repair. chest pain. left ventricular function. mitral valve disease. preoperative assessment. pulmonary hypertension. right ventricular function. icd-9 codes: 786.51, 424.0, 424.2 test information date/time: at 09:10 interpret md: , md test type: tee (complete) son: , md doppler: full doppler and color doppler test location: anesthesia west or cardiac contrast: none tech quality: adequate tape #: 2010aw2-: machine: echocardiographic measurements results measurements normal range left atrium - peak pulm vein s: 0.2 m/s left atrium - peak pulm vein d: 0.4 m/s left ventricle - ejection fraction: 35% >= 55% aorta - ascending: 3.1 cm <= 3.4 cm findings right atrium/interatrial septum: a catheter or pacing wire is seen in the ra and extending into the rv. no asd by 2d or color doppler. left ventricle: moderate regional lv systolic dysfunction. moderately depressed lvef. no resting lvot gradient. right ventricle: mild global rv free wall hypokinesis. aorta: normal aortic diameter at the sinus level. normal ascending aorta diameter. complex (>4mm) atheroma in the descending thoracic aorta. aortic valve: normal aortic valve leaflets (3). no as. no ar. mitral valve: mildly thickened mitral valve leaflets. mild mitral annular calcification. no ms. moderate (2+) mr. tricuspid valve: mild tr. pericardium: no pericardial effusion. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. the patient was under general anesthesia throughout the procedure. no tee related complications. the patient appears to be in sinus rhythm. results were personally reviewed with the md caring for the patient. regional left ventricular wall motion: n = normal, h = hypokinetic, a = akinetic, d = dyskinetic conclusions prebypass no atrial septal defect is seen by 2d or color doppler. there is moderate regional left ventricular systolic dysfunction with hypokinesia of the apical and mid portions of the inferior, inferolateral and inferoseptal walls.. overall left ventricular systolic function is moderately depressed (lvef= 35 %). with mild global rv free wall hypokinesis. there are complex (>4mm) atheroma in the descending thoracic aorta. the aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic regurgitation. the mitral valve leaflets are mildly thickened. moderate (2+) mitral regurgitation is seen. there is no pericardial effusion. dr. was notified in person of the results on at 900am post bypass patient is av paced and receiving an infusion of phenylephrine and epinephrine. biventricular systolic function is unchanged. annuloplasty ring seen in the mitral position. appears well seated. mild mitral regurgitation persists. mean gradient across the mitral valve is 4 mm hg. dr aware. aorta is intact post decannulation. i certify that i was present for this procedure in compliance with hcfa regulations. electronically signed by , md, interpreting physician 14:19 brief hospital course: was admitted same day surgery and underwent coronary artery bypass grafting and a mitral valve repair. for surgical details, please see operative note. following the operation, he was brought to the cvicu for invasive monitoring. he took several days to wean from inotropic support. on postoperative day three, he transferred to the stepdown unit for ongoing post-operative care. he was started on betablockers, statins and diuresed toward his pre-operative weight. he was slow to wean from supplemental oxygen due to persistent left effusion requiring more aggressive diuresis. he responded well to additional iv lasix and zaroxolyn with oxygen saturation 93% on room air at the time of discharge. he was evaluated and treated by physical therapy for strength and conditioning. he was discharged to home on pod#8 in stable condition. medications on admission: lasix 40mg qd atenolol 25mg qd aspirin 325mg qd zocor 20mg qd omeprazole 20mg qd discharge medications: 1. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). disp:*30 capsule, delayed release(e.c.)(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 4. simvastatin 20 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* 5. lisinopril 5 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 6. hydromorphone 2 mg tablet sig: 1-2 tablets po q3h (every 3 hours) as needed for pain. disp:*60 tablet(s)* refills:*0* 7. albuterol sulfate 90 mcg/actuation hfa aerosol inhaler sig: two (2) puff inhalation q6h (every 6 hours). disp:*qs qs* refills:*0* 8. furosemide 40 mg tablet sig: one (1) tablet po daily (daily) for 2 weeks: please follow up with cardiologist prior to completion . disp:*14 tablet(s)* refills:*0* 9. carvedilol 12.5 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*0* 10. potassium chloride 10 meq capsule, sustained release sig: one (1) capsule, sustained release po once a day for 2 weeks. disp:*14 capsule, sustained release(s)* refills:*0* discharge disposition: home with service facility: vna discharge diagnosis: coronary artery disease, mitral valve regurgitation chronic systolic congestive heart failure hypertension dyslipidemia copd discharge condition: alert and oriented x3 nonfocal ambulating, gait steady sternal pain managed with dilaudid prn discharge instructions: please shower daily including washing incisions gently with mild soap, no baths or swimming, and look at your incisions please no lotions, cream, powder, or ointments to incisions each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart no driving for approximately one month until follow up with surgeon no lifting more than 10 pounds for 10 weeks please call with any questions or concerns followup instructions: please call to schedule appointments surgeon dr. in 4 weeks at 1:30 pm primary care dr. in weeks cardiologist dr. in weeks wound check appointment - 6 () - your nurse will schedule procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries open heart valvuloplasty of mitral valve without replacement diagnoses: coronary atherosclerosis of native coronary artery mitral valve disorders congestive heart failure, unspecified unspecified essential hypertension chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia acute on chronic systolic heart failure long-term (current) use of aspirin 

Answer: The patient is high likely exposed to